Save Daliresp for SEVERE COPD Patients With Frequent Exacerbations

New data will help clarify when to use Daliresp (roflumilast) to prevent COPD exacerbations.

You may hear that Daliresp decreases hospitalizations due to COPD exacerbations by 25%. This works out to one fewer hospitalization for every 24 severe COPD patients on Daliresp for a year.

Continue to maximize bronchodilators and inhaled steroids first. Ensure that patients are using their inhalers properly and consistently.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote